Scarica l'app Stockscreener
2.82
2.76%
-0.08
Pre-mercato:
2.80
-0.02
-0.71%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACHV Giù?
Forum
Previsione
Frazionamento azionario
Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie
HC Wainwright Reiterates "Buy" Rating for Achieve Life Sciences (NASDAQ:ACHV) - MarketBeat
H.C. Wainwright reiterates Buy on Achieve Life Sciences stock By Investing.com - Investing.com Canada
Achieve Life Sciences (ACHV): HC Wainwright & Co. Reiterates Buy Rating | ACHV Stock News - GuruFocus
Earnings Call Summary | Achieve Life(ACHV.US) Q4 2025 Earnings Conference - 富途牛牛
Achieve Life Sciences outlines first half 2027 cytisinicline launch supported by US manufacturing shift and AI-driven commercialization - MSN
Achieve Life Sciences stock falls as commercial launch pushed to 2027 - Investing.com Canada
Achieve Life Sciences Inc (ACHV) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial Challenges - GuruFocus
Achieve Life Sciences Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - marketscreener.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Achieve Life Sciences Reports 2025 Financial Results, Advances Cytisinicline NDA for Smoking and Vaping Cessation, Announces U.S. Manufacturing Partnership with Adare Pharma Solutions 12 - Minichart
Achieve Life Sciences Sees Unusually Large Options Volume (NASDAQ:ACHV) - MarketBeat
Achieve Life Sciences Q4 Earnings Call Highlights - MarketBeat
Achieve Life Sciences, Inc. 2025 10-K Annual Report: Business Overview, Risk Factors, and Financial Highlights - Minichart
ACHV: Cytisinicline NDA accepted; U.S. launch planned for 1H 2027 with robust supply and payer strategy - TradingView
Achieve Life Sciences reports fourth-quarter results in line with expectations - MSN
ACHV: NDA review progresses for cytisinicline, with U.S. launch targeted for 1H 2027 amid strong clinical data - TradingView
Earnings call transcript: Achieve Life Sciences Q4 2025 reports stable EPS, stock dips - Investing.com
Achieve (ACHV) Advances Cytisinicline for Smoking Cessation Solu - GuruFocus
Sanara MedTech Inc. (SMTI) Misses Q4 EPS Estimates by 215.9% - AlphaStreet
Achieve Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Achieve Life Sciences, Inc. (ACHV) Reports Wider Q4 Loss Than Expected - AlphaStreet
Achieve Life Sciences meets fourth quarter estimates By Investing.com - Investing.com Australia
Achieve Life Sciences (NASDAQ:ACHV) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
Achieve Life Sciences meets fourth quarter estimates - Investing.com
ACHIEVE LIFE SCIENCES ($ACHV) Releases Q4 2025 Earnings - Quiver Quantitative
Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - The Manila Times
Achieve Life Sciences 2025 10-K: Net loss $54.6M, EPS $(1.25) - TradingView
Earnings Scheduled For March 24, 2026 - Benzinga
Cytisinicline outlook at Achieve Life Sciences (NASDAQ: ACHV) amid FDA review and cash risk - Stock Titan
Achieve Life Sciences (NASDAQ: ACHV) deepens 2025 loss while eyeing 2026 FDA decision - Stock Titan
Achieve taps U.S. manufacturer for quit-smoking pill ahead of FDA date - Stock Titan
Achieve Life Sciences (ACHV) Q4 Earnings Preview: What to Expect - GuruFocus
Achieve Life Sciences Inc expected to post a loss of 27 cents a shareEarnings Preview - TradingView
Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026 - The Manila Times
Nicotine-dependence drug developer schedules March 24 update on 2025 results - Stock Titan
Activity Recap: How does Achieve Life Sciences Inc score in quality rankingsPrice Action & AI Driven Stock Reports - baoquankhu1.vn
Achieve Life Sciences, Inc. $ACHV Shares Sold by Clearline Capital LP - MarketBeat
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200 Day Moving Average – Time to Sell? - Defense World
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200 Day Moving AverageTime to Sell? - MarketBeat
ACHV PE Ratio & Valuation, Is ACHV Overvalued - Intellectia AI
Achieve Life Sciences, Inc. advances novel smoking cessation treatment at SRNT2026 - Traders Union
How Achieve Life Sciences Inc. stock reacts to global recession fearsQuarterly Market Review & AI Enhanced Trading Signals - Naître et grandir
Aug Breakouts: Is Achieve Life Sciences Inc stock influenced by commodity pricesWeekly Profit Analysis & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Achieve Life Sciences outlines Late-breaking survey results on ORCA-OL unveiled - Traders Union
Achieve Life Sciences, Inc. $ACHV Shares Sold by Propel Bio Management LLC - MarketBeat
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Achieve Life Sciences presents cytisinicline quit-smoking data - Investing.com
Achieve Life Sciences presents cytisinicline quit-smoking data By Investing.com - Investing.com UK
Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study - marketscreener.com
New study: smokers who failed other quit drugs stop with cytisinicline - Stock Titan
ACHV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Achieve Life Sciences (ACHV) Expected to Announce Earnings on Tuesday - MarketBeat
Caris Life Sciences Completes Interim Readout of Achieve 1 Study - Finviz
/C O R R E C T I O N -- Caris Life Sciences/ - PR Newswire
Achieve Life Sciences, Inc. advances new smoking cessation treatment as over 16 million Americans face heart disease - Traders Union
Achieve Life Sciences (NASDAQ:ACHV) Shares Pass Above 200 Day Moving AverageWhat's Next? - MarketBeat
ACHV SEC FilingsAchieve Life Sciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
What is Achieve Life Sciences Inc.’s book value per sharePortfolio Value Report & Real-Time Stock Entry Alerts - mfd.ru
Aug Reactions: Whats the MACD signal for Achieve Life Sciences Inc2025 Macro Impact & Smart Money Movement Alerts - baoquankhu1.vn
Achieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200 Day Moving AverageWhat's Next? - MarketBeat
Achieve Life Sciences stock falls after pricing capital raise of $45M via securities offering - MSN
Is Achieve Life Sciences Inc. stock trending bullishWeekly Loss Report & Fast Momentum Entry Tips - mfd.ru
Achieve Life Sciences appoints Oki as Chief Financial Officer - Intellectia AI
What are Achieve Life Sciences Inc.’s recent SEC filings showingGlobal Markets & Precise Buy Zone Identification - mfd.ru
Why Achieve Life Sciences Inc. stock appeals to dividend seekers2025 Analyst Calls & Long-Term Growth Stock Strategies - mfd.ru
Alert wrongly tagged to Achieve Life Sciences withdrawn - marketscreener.com
Will Achieve Life Sciences Inc. (SP4P) stock outperform small cap peersEarnings Risk Summary & Low Risk Entry Point Guides - mfd.ru
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):